Back to Search Start Over

EVALI versus MIS-C, one more overlapping diagnosis to consider.

Authors :
Cruz-Vidal DA
Mull ES
Taveras J
Shell R
Hunt GW
Fowler B
Wallihan R
Erdem G
Source :
Pediatric pulmonology [Pediatr Pulmonol] 2021 Sep; Vol. 56 (9), pp. 2918-2924. Date of Electronic Publication: 2021 Jul 16.
Publication Year :
2021

Abstract

We describe six teenagers presenting with fever and severe abdominal symptoms admitted with concerns for multisystem inflammatory syndrome in children (MIS-C). Laboratory evaluation revealed elevated markers of inflammation, lymphopenia, and increased D-dimers. Imaging studies revealed multifocal airspace disease and ground-glass opacities. SARS-CoV-2 polymerase chain reaction and serologies were negative. All patients reported a history of vaping, prompting E-cigarette, or vaping, product use-associated lung injury (EVALI) diagnosis. MIS-C has overlapping clinical and laboratory features highlighting the added challenge of diagnosing EVALI during the COVID-19 pandemic. Keywords COVID-19 pandemic, EVALI, MIS-C.<br /> (© 2021 Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1099-0496
Volume :
56
Issue :
9
Database :
MEDLINE
Journal :
Pediatric pulmonology
Publication Type :
Academic Journal
Accession number :
34219413
Full Text :
https://doi.org/10.1002/ppul.25558